Literature DB >> 18178783

Does lowering of blood glucose improve cardiovascular morbidity and mortality?

Nayyar Iqbal1, Arthur H Rubenstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18178783     DOI： 10.2215/CJN.05041107

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  5 in total

1.  Better risk assessment with glycated hemoglobin instead of cholesterol in CVD risk prediction charts.

Authors:  David Faeh; Sabine Rohrmann; Julia Braun
Journal:  Eur J Epidemiol       Date:  2013-07-17       Impact factor: 8.082

2.  Explanatory models of heart failure etiology.

Authors:  Angela P Clark; Graham J McDougall; Glenda Joiner-Rogers; Sheri Innerarity; Carol Delville; Marty Meraviglia; Ashley Davila
Journal:  Dimens Crit Care Nurs       Date:  2012 Jan-Feb

3.  Meta-analyses of the association of G6PC2 allele variants with elevated fasting glucose and type 2 diabetes.

Authors:  Yuanyuan Shi; Yuqian Li; Jinjin Wang; Chongjian Wang; Jingjing Fan; Jingzhi Zhao; Lei Yin; Xuejiao Liu; Dongdong Zhang; Linlin Li
Journal:  PLoS One       Date:  2017-07-13       Impact factor: 3.240

4.  Gene-gene interactions lead to higher risk for development of type 2 diabetes in a Chinese Han population: a prospective nested case-control study.

Authors:  Wen Zhou; Yuqian Li; Lulu Zhang; Yuanyuan Shi; Chongjian Wang; Dongdong Zhang; Xuejiao Liu; Zhenxing Mao; Linlin Li
Journal:  Lipids Health Dis       Date:  2018-07-28       Impact factor: 3.876

5.  Blood glucose may be an alternative to cholesterol in CVD risk prediction charts.

Authors:  Julia Braun; Matthias Bopp; David Faeh
Journal:  Cardiovasc Diabetol       Date:  2013-01-25       Impact factor: 9.951
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.